Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AKYA NYSEAMERICAN:KNW OTCMKTS:MEEC NASDAQ:ODYS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKYAAkoya Biosciences$1.29$1.26$0.93▼$3.42$64.44M1.36416,191 shsN/AKNWKNOW LABS$2.44-14.7%$2.18$0.33▼$16.34$21.45M1.77823,196 shs511,677 shsMEECMidwest Energy Emissions$0.65+4.8%$0.59$0.35▼$1.40$61.34M1.53141,925 shs99,300 shsODYSOdysight.ai$4.62+1.5%$5.04$4.00▼$10.80$74.24M0.3812,114 shs3,661 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKYAAkoya Biosciences0.00%0.00%+0.78%-0.77%-46.03%KNWKNOW LABS-14.69%-6.51%+19.61%+435.44%-84.53%MEECMidwest Energy Emissions-2.36%+1.64%-7.46%+14.81%-12.66%ODYSOdysight.ai+1.54%-3.75%-3.14%-16.76%+461,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAKYAAkoya Biosciences1.5475 of 5 stars3.03.00.00.00.01.70.6KNWKNOW LABSN/AN/AN/AN/AN/AN/AN/AN/AMEECMidwest Energy EmissionsN/AN/AN/AN/AN/AN/AN/AN/AODYSOdysight.ai1.9524 of 5 stars3.50.00.00.03.40.80.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAKYAAkoya Biosciences 2.00Hold$2.5194.26% UpsideKNWKNOW LABS 0.00N/AN/AN/AMEECMidwest Energy Emissions 0.00N/AN/AN/AODYSOdysight.ai 3.00Buy$10.00116.45% UpsideCurrent Analyst Ratings BreakdownLatest KNW, ODYS, AKYA, and MEEC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2025AKYAAkoya BiosciencesCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$1.80 ➝ $1.084/29/2025AKYAAkoya BiosciencesCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$3.50 ➝ $1.80(Data available from 7/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKYAAkoya Biosciences$79.96M0.81N/AN/A$0.15 per share8.60KNWKNOW LABS$4.36M4.20N/AN/A($0.80) per share-3.05MEECMidwest Energy Emissions$17.94M3.42N/AN/A($0.01) per share-65.00ODYSOdysight.ai$3.96M19.04N/AN/A$1.45 per share3.19Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKYAAkoya Biosciences-$55.37M-$0.97N/AN/AN/A-59.44%-487.85%-35.86%8/4/2025 (Estimated)KNWKNOW LABS-$16.58M-$0.20N/A∞N/AN/AN/A-720.15%N/AMEECMidwest Energy Emissions$5.90M$0.04N/A∞N/A-3.40%N/A-129.96%N/AODYSOdysight.ai-$11.77M-$1.02N/A∞N/A-220.30%-58.27%-47.55%N/ALatest KNW, ODYS, AKYA, and MEEC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2025Q2 2025AKYAAkoya Biosciences-$0.22N/AN/AN/A$18.10 millionN/A5/15/2025Q1 2025ODYSOdysight.aiN/A-$0.29N/A-$0.29N/A$2.07 million5/12/2025Q1 2025AKYAAkoya Biosciences-$0.29-$0.32-$0.03-$0.32$20.19 million$16.64 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAKYAAkoya BiosciencesN/AN/AN/AN/AN/AKNWKNOW LABSN/AN/AN/AN/AN/AMEECMidwest Energy EmissionsN/AN/AN/AN/AN/AODYSOdysight.aiN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAKYAAkoya Biosciences10.120.610.40KNWKNOW LABSN/A0.070.07MEECMidwest Energy EmissionsN/A1.741.59ODYSOdysight.aiN/A11.1411.14Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKYAAkoya Biosciences79.42%KNWKNOW LABS23.96%MEECMidwest Energy Emissions9.87%ODYSOdysight.ai19.67%Insider OwnershipCompanyInsider OwnershipAKYAAkoya Biosciences7.30%KNWKNOW LABS35.80%MEECMidwest Energy Emissions31.00%ODYSOdysight.aiN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAKYAAkoya Biosciences9049.95 million46.31 millionOptionableKNWKNOW LABS207.50 million4.82 millionNot OptionableMEECMidwest Energy Emissions1294.37 million65.12 millionNot OptionableODYSOdysight.ai4016.32 millionN/AN/AKNW, ODYS, AKYA, and MEEC HeadlinesRecent News About These CompaniesPhoenix Financial Ltd. Makes New $15.26 Million Investment in Odysight.ai Inc. (NASDAQ:ODYS)July 26 at 8:11 AM | marketbeat.comODYSIGHT.AI AND A MULTINATIONAL TECHNOLOGY GROUP SIGN STRATEGIC COLLABORATION AGREEMENT AIMED TO DEPLOY PREDICTIVE MAINTENANCE CAPABILITIES ACROSS MULTIPLE PLATFORMSJuly 22, 2025 | globenewswire.comOdysight.ai (NASDAQ:ODYS) Trading Down 1.4% - Here's WhyJuly 4, 2025 | marketbeat.comOdysight.AI (Nasdaq: ODYS) Added to the Russell Microcap® IndexJuly 1, 2025 | globenewswire.comODYSIGHT.AI is strengthening its European Presence to Accelerate Industry 4.0: received Initial Order from Leading EU Player for AI-Driven industrial predictive health monitoring solutions"June 16, 2025 | globenewswire.comOdysight.ai to Participate in the 15th Annual ROTH London Conference on June 25 and 26June 12, 2025 | globenewswire.comInsider Selling: Odysight.Ai Inc. (NASDAQ:ODYS) Major Shareholder Sells 8,600 Shares of StockMay 22, 2025 | insidertrades.comOdysight.ai Reports Financial Results for The First Quarter of 2025 and Provides Business UpdateMay 15, 2025 | globenewswire.comOdysight.ai to participate at MRO Americas 2025 - International trade fair in the Aerospace IndustryApril 2, 2025 | globenewswire.comOdysight.ai Reports Full Year 2024 Financial Results and Provides Business UpdateMarch 26, 2025 | globenewswire.comInsider Selling: Odysight.Ai Inc. (NASDAQ:ODYS) Major Shareholder Sells 2,400 Shares of StockMarch 14, 2025 | insidertrades.comOdysight.ai to Participate at the 37th Annual ROTH Conference on March 17-18, 2025March 3, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeKNW, ODYS, AKYA, and MEEC Company DescriptionsAkoya Biosciences NASDAQ:AKYA$1.29 0.00 (0.00%) As of 07/8/2025Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.KNOW LABS NYSEAMERICAN:KNW$2.44 -0.42 (-14.69%) Closing price 07/25/2025 04:10 PM EasternExtended Trading$2.48 +0.04 (+1.64%) As of 07/25/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was incorporated in 1998 and is based in Seattle, Washington.Midwest Energy Emissions OTCMKTS:MEEC$0.65 +0.03 (+4.84%) As of 07/25/2025Midwest Energy Emissions Corp., an environmental services and technology company, engages in developing and delivering solutions to the power industry in the United States and internationally. It provides mercury capture solutions. Its Sorbent Enhancement Additive (SEA) technology provides total mercury control with solutions that are based on a thorough scientific understanding of actual and probable interactions involved in mercury capture in coal-fired flue gas. The company also involved in the extracting and processing of rare earth elements. Midwest Energy Emissions Corp. is headquartered in Corsicana, Texas.Odysight.ai NASDAQ:ODYS$4.62 +0.07 (+1.54%) As of 07/25/2025 03:52 PM EasternOdysight.ai, Inc. engages in the development and manufacture of customized visual solutions for organizations across a variety of industries in the form of micro cameras and supplementary technologies. Its devices can used across the medical, aerospace, industrial, research, and defense industries. The company was founded on March 22, 2013 and is headquartered in Omer, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Intel's Turnaround Gains Credibility With Strong Q2 Report Qualcomm's Next Gear: A Growth Story Wall Street Might Be Missing Krispy Kreme: A Meme Stock Sugar Rush or a Sustainable Treat? From Zero to Hero? Why GoPro's Rally Could Be More Than It Seems CrowdStrike Scores Big With Gartner, But Valuation Is Stretched ServiceNow: The 2nd Wave of AI Spending Is Here Tractor Supply Revs Up on Forecast Hike and Bullish Signals A Smokin’ Hot Entry Point for Chipotle Stock Opens in Q3 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
